Press Releases

ENGLEWOOD, Colo., Dec. 4, 2019 /PRNewswire/ -- Medical Group Management Associatio

PRINCETON, N.J. and SAN DIEGO, Dec. 4, 2019 /PRNewswire/ -- Adastra Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of first-in-class therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have granted Orphan Drug Desi

HAYWARD, Calif., Dec. 4, 2019 /PRNewswire/ -- OptiScan Biomedical Corporation, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit (SICU), today announced the online publication of two peer-reviewed papers highlighting key benefits delivered by the company's OptiScanner continuous monitoring platform for intensive ca

SALT LAKE CITY, Dec. 4, 2019 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services

BOSTON, Dec. 4, 2019 /PRNewswire/ -- COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is presenting posters at the American Society of Hematology Annual Meeting & Exposition, ASH 2019, in Orlando, FL from December 7-10, 2019. Collecti

NEW YORK, Dec. 4, 2019 /PRNewswire/ -- Deloitte and Tisch MS Research Center of New York (Tisch MSRCNY) are using data science, artificial intelligence (AI) and machine learning in a multiphase research project to find patterns that may relate to the cause of multiple sclerosis (MS).

NEW YORK and PARIS, Dec. 4, 2019 /PRNewswire/ -- Global marketing and communications firm 

WORCESTER, Mass., Dec. 4, 2019 /PRNewswire/ -- Manna Molecular Science, LLC (MANNA), a producer of human-centered hemp and cannabis products, today announced the commer

CRANFORD, N.J., Dec. 4, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at the 12th Annual LD Micro Main Event on Wednesday December 11, 2019

PORT WASHINGTON, New York, Dec. 4, 2019 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, has marked  its 10-year milestone and has retained a highly aggressive year over year growth rate as it moves into 2020.F